Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C7GJ
|
|||
Former ID |
DIB008442
|
|||
Drug Name |
Long-acting factor VIII
|
|||
Synonyms |
PolyXen PSA-Factor VIII; Long-acting factor VIII (PolyXen, blood clotting disorder); Polysialic factor VIII (PolyXen, blood clotting disorder), Lipoxen/Baxter; Long-acting factor VIII (PolyXen, blood clotting disorder), Lipoxen/Baxter
Click to Show/Hide
|
|||
Indication | Coagulation defect [ICD-11: 3B10.0; ICD-9: 286] | Investigative | [1] | |
Company |
Baxter International Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Coagulation factor VIII (F8) | Target Info | Modulator | [1] |
KEGG Pathway | Complement and coagulation cascades | |||
Panther Pathway | Blood coagulation | |||
Pathwhiz Pathway | Coagulation | |||
Reactome | Platelet degranulation | |||
Intrinsic Pathway of Fibrin Clot Formation | ||||
Common Pathway of Fibrin Clot Formation | ||||
COPII (Coat Protein 2) Mediated Vesicle Transport | ||||
Cargo concentration in the ER | ||||
WikiPathways | Complement and Coagulation Cascades | |||
Blood Clotting Cascade | ||||
Formation of Fibrin Clot (Clotting Cascade) |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2607). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.